CUR Quote, Trading Chart, Neuralstem Inc.
$ Last:
-2.27% Change Percent:
$1.24 Open:
$1.29 Previous Close:
$1.29 High:
$1.20 Low:
78,429 Volume:
01/01/1970 12:00:00 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
CUR Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2019-10-17 | 1.24 | 1.29 | 1.29 | 1.20 | 78,429 |
| 2019-10-16 | 1.36 | 1.32 | 1.66 | 1.25 | 883,783 |
| 2019-10-15 | 1.29 | 1.35 | 1.40 | 1.23 | 101,489 |
| 2019-10-14 | 1.30 | 1.30 | 1.35 | 1.22 | 169,150 |
| 2019-10-11 | 1.22 | 1.15 | 1.30 | 1.1414 | 138,300 |
| 2019-10-10 | 1.21 | 1.21 | 1.25 | 1.19 | 16,832 |
| 2019-10-09 | 1.28 | 1.22 | 1.30 | 1.10 | 70,035 |
| 2019-10-08 | 1.35 | 1.28 | 1.37 | 1.22 | 86,448 |
| 2019-10-07 | 1.40 | 1.37 | 1.45 | 1.32 | 41,235 |
| 2019-10-04 | 1.47 | 1.41 | 1.52 | 1.28 | 112,756 |
| 2019-10-03 | 1.61 | 1.45 | 1.64 | 1.41 | 82,980 |
| 2019-10-02 | 1.67 | 1.60 | 1.68 | 1.56 | 68,510 |
| 2019-10-01 | 1.66 | 1.69 | 1.75 | 1.63 | 108,141 |
| 2019-09-30 | 1.68 | 1.67 | 1.71 | 1.62 | 46,698 |
| 2019-09-27 | 1.63 | 1.68 | 1.72 | 1.62 | 31,140 |
| 2019-09-26 | 1.60 | 1.68 | 1.69 | 1.57 | 33,530 |
| 2019-09-25 | 1.61 | 1.62 | 1.68 | 1.55 | 70,361 |
| 2019-09-24 | 1.73 | 1.63 | 1.78 | 1.58 | 198,375 |
| 2019-09-23 | 1.69 | 1.70 | 1.81 | 1.57 | 114,961 |
| 2019-09-20 | 1.69 | 1.69 | 1.7355 | 1.57 | 68,490 |
News, Short Squeeze, Breakout and More Instantly...
-
RADNOR, Pa., March 19, 2021 (GLOBE NEWSWIRE) -- NeuroRx, Inc. announced the first patient in its P2/3 study of inhaled ZYESAMI™ in the treatment of moderate and severe COVID-19 (AVICOVID-2) was dosed at the University of California Irvine. The trial will be conducted at 10-15 clinica...
-
GERMANTOWN, Md. , Sept. 2, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA), a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today provided the following letter from Dr. Ken Carter , the Company's Executive Chairm...
-
GERMANTOWN, Md. , May 27, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq:SNCA), a clinical-stage biopharmaceutical company developing novel treatments for various diseases of high unmet medical need, today announced the closing of its previously announced $5 million registered...